| 000 | 01738 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515194331.0 | ||
| 264 | 0 | _c20100408 | |
| 008 | 201004s 0 0 fre d | ||
| 022 | _a0151-9638 | ||
| 024 | 7 |
_a10.1016/j.annder.2009.09.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAdenis-Lamarre, E | |
| 245 | 0 | 0 |
_a[Cutaneous infection due to Mycobacterium chelonae during anti-TNF therapy]. _h[electronic resource] |
| 260 |
_bAnnales de dermatologie et de venereologie _cNov 2009 |
||
| 300 |
_a811-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmoxicillin-Potassium Clavulanate Combination _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xdiagnosis |
| 650 | 0 | 4 | _aMycobacterium chelonae |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aSkin _xpathology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aKostrzewa, E | |
| 700 | 1 | _aTexier-Maugein, J | |
| 700 | 1 | _aDoutre, M S | |
| 773 | 0 |
_tAnnales de dermatologie et de venereologie _gvol. 136 _gno. 11 _gp. 811-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.annder.2009.09.008 _zAvailable from publisher's website |
| 999 |
_c19303374 _d19303374 |
||